Join to View Full Profile
9200 W Wisconsin AveMilwaukee, WI 53226
Phone+1 414-805-4600
Fax+1 414-805-6805
Dr. Longo is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Wisconsin Hospitals and ClinicsFellowship, Medical Oncology, 1984 - 1985- University of Wisconsin Hospitals and ClinicsFellowship, Hematology and Medical Oncology, 1982 - 1984
Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1977 - 1980
University of Nebraska College of MedicineClass of 1977
Certifications & Licensure
WI State Medical License 1982 - 2027
IL State Medical License 1994 - 1996
MN State Medical License 1978 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2012-2017
- CMS Meaningful Use Stage 1 Certification PRISM, IOD Incorporated, 2012-2017
Clinical Trials
- Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202) Start of enrollment: 2004 Aug 01
- Rituxan/BEAM vs Bexxar/BEAM in Autologous Hematopoietic Stem Cell Transplant for Non-Hodgkin's Lymphoma (BMTCTN0401) Start of enrollment: 2005 Dec 01
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- Financial Toxicity in a Phase I/II Trial of LV20.19 CAR-T Cell for B-cell Malignancies: A Longitudinal, Qualitative Study.Elizabeth Aughey, Nirav N Shah, Cecilia J Hillard, Kelly E Rentscher, Mehdi Hamadani
Transplantation and Cellular Therapy. 2026-05-01 - Tildrakizumab for the prophylaxis of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Lyndsey Runaas, Salena Fank, Katie Palen, Aniko Szabo, Lisa E Rein
Blood Advances. 2026-04-28 - 7 citationsPhase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma.Nirav N Shah, Alfredo S Colina, Bryon D Johnson, Aniko Szabo, Fateeha Furqan
Journal of Clinical Oncology. 2025-07-10
Journal Articles
- Related Peripheral Blood Stem Cell Donors Experience More Severe Symptoms and Less Complete Recovery at 1-Year Compared to Unrelated DonorsParameswaran N Hari, David A Jacobsohn, Joseph P McGuirk, Mary M Horowitz, Walter Longo, Thomas Spitzer, Daniel J Weisdorf, Shahram Mori, David C Delgado, Marcie L Ric..., Haematologica
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
